(Bloomberg) -- China’s probe into AstraZeneca Plc has reached its ... In 2013, GSK Plc admitted that its sales organization ...

AstraZeneca has shown its commitment to China amid investigations into its executives and activities, outlining plans to establish a global strategic R&D center in Beijing as part of a $2.5 ...

Pascal Soriot, AstraZeneca’s chief executive, says the investment ‘reflects our belief in the world-class life sciences ecosystem in Beijing’ - Zach Gibson/Bloomberg AstraZeneca has unveiled ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...

The centre in Beijing will be the company's second R&D site in China - a centre in Shanghai opened in 2024 - to match two such centres each that AstraZeneca has in the U.S. and Europe ...

Five current and former AstraZeneca employees have reportedly been detained in China in connection with a pair of investigations. The investigations concern the importation of an unapproved liver ...

The U.K. pharmaceutical company AstraZeneca has become the largest multinational drugmaker in China, drawing 13% of its $5.8 billion in revenue last year from there, against a backdrop of an acute ...

AstraZeneca is investing $2.5bn in research and development and manufacturing in Beijing, as the drugmaker tries to move on after a scandal that led to the detention of a top executive in China.

AstraZeneca shares declined Tuesday after reports that senior executives in China were potentially implicated in an insurance fraud case. AstraZeneca China President Leon Wang is cooperating with ...

as strength in its oncology business offset weak China sales, but warned of a potential fine from a drug-import probe in the country. The results lifted AstraZeneca’s shares, which rose as much ...

LONDON, Nov 6 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not know the reason ...